97
98
[14] Higgins GM. A. RM, “Experimental pathology of the liver, 1: Restoration of the liver of the white rat following partial surgical removal.,” Arch Pathol., 12, 186-202, 1931.
[15] He Y, Zhou J, Dou KF, Chen Y., “A rat model for acute hepatic failure.,” Hepatobiliary Pancreat Dis Int. , 2, 423-425, 2003.
[16] Ijima H, Noguchi A, Katsuno T, Ono T, Nakazawa K, Funatsu K, Kawakami K.,
“Evaluating the performance of a hybrid artificial liver support system with a recoverable hepatic failure rat model.,” Ann N Y Acad Sci., 944, 344-349, 2001.
[17] Mullen KD, Birgisson S, Gacad RC, Conjeevaram H., “Animal models of hepatic encephalopathy and hyperammonemia.,” Adv Exp Med Biol., 368, 1-10, 1994.
[18] Wang JB, Wang HT, Li LP, Yan YC, Wang W, Liu JY, Zhao YT, Gao WS, Zhang MX.,
“Development of a rat model of D-galactosamine/lipopolysaccharide induced hepatorenal syndrome.,” World J Gastroenterol., 21, 34, 9927-9935, 2015.
[19] James LP, Mayeux PR, Hinson JA., “Acetaminophen-induced hepatotoxicity.,”
Drug Metab Dispos., 31, 12, 1499-1506, 2018.
[20] Eguchi S, Kamlot A, Ljubimova J, Hewitt WR, Lebow LT, Demetriou AA, Rozga J.,
“Fulminant hepatic failure in rats: survival and effect on blood chemistry and liver regeneration.,” Hepatology., 24, 6, 1452-1459, 1996.
[21] He Y, Zhou J, Dou KF, Chen Y., “A rat model for acute hepatic failure.,” Hepatobiliary Pancreat Dis Int. , 2, 3, 423-425, 2003.
[22] STARZL TE, MARCHIORO TL, VONKAULLA KN, HERMANN G, BRITTAIN RS, WADDELL WR., “HOMOTRANSPLANTATION OF THE LIVER IN HUMANS.,”
Surg Gynecol Obstet., 117, 659-676, 1963.
[23] Meirelles Júnior RF, Salvalaggio P, Rezende MB, Evangelista AS, Guardia BD, Matielo CE, Neves DB, Pandullo FL, Felga GE, Alves JA, Curvelo LA, Diaz LG, Rusi MB, Viveiros Mde M, Almeida MD, Pedroso PT, Rocco RA, Meira Filho SP.,
“Liver transplantation: history, outcomes and perspectives.,” Einstein (Sao Paulo)., 13, 1, 149-152, 2015.
99
[24] 日本臓器移植ネットワーク, 移植に関するデータ 累計登録者数, 2018.
[25] 後藤満一、大橋一夫, 著: 再生医療叢書5 代謝系臓器, 朝倉書店, 2012, 133-141.
[26] 後藤満一、大橋一夫, 著: 再生医療叢書5代謝系臓器, 朝倉書店, 2012, 141-147.
[27] Phillips TJ, Manzoor J, Rojas A, Isaacs C, Carson P, Sabolinski M, Young J, Falanga V., “The longevity of a bilayered skin substitute after application to venous ulcers.,” Arch Dermatol. , 138, 8, 1079-1081, 2002.
[28] Brittberg M, Lindahl A, Nilsson A, Ohlsson C, Isaksson O, Peterson L., “Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation.,”
N Engl J Med., 331, 14, 889-895, 1994.
[29] Nishida K, Yamato M, Hayashida Y, Watanabe K, Yamamoto K, Adachi E, Nagai S, Kikuchi A, Maeda N, Watanabe H, Okano T, Tano Y., “Corneal reconstruction with tissue-engineered cell sheets composed of autologous oral mucosal epithelium.,” N Engl J Med., 351, 12, 1187-1196, 2004.
[30] Shimizu T, Sekine H, Isoi Y, Yamato M, Kikuchi A, Okano T., “Long-term survival and growth of pulsatile myocardial tissue grafts engineered by the layering of cardiomyocyte sheets.,” Tissue Eng., 12, 3, 499-507, 2006.
[31] 後藤満一、大橋一夫, 著: 再生医療叢書5代謝系臓器, 朝倉書店, 2012, 123-132.
[32] Smith MK, Riddle KW, Mooney DJ., “Delivery of hepatotrophic factors fails to enhance longer-term survival of subcutaneously transplanted hepatocytes.,” Tissue Eng., 12, 2, 235-244, 2006.
[33] Chen AA, Thomas DK, Ong LL, Schwartz RE, Golub TR, Bhatia SN., “Humanized mice with ectopic artificial liver tissues.,” Proc Natl Acad Sci U S A. , 108, 29, 11842-11847, 2011.
[34] Ohashi K, Yokoyama T, Yamato M, Kuge H, Kanehiro H, Tsutsumi M, Amanuma T, Iwata H, Yang J, Okano T, Nakajima Y., “Engineering functional two- and three-dimensional liver systems in vivo using hepatic tissue sheets.,” Nat Med. , 13, 7, 880-885, 2007.
100
[35] Matsuura K, Haraguchi Y, Shimizu T, Okano T., “Cell sheet transplantation for heart tissue repair.,” J Control Release., 169, 3, 336-340, 2013.
[36] Sasagawa T, Shimizu T, Sekiya S, Haraguchi Y, Yamato M, Sawa Y, Okano T.,
“Design of prevascularized three-dimensional cell-dense tissues using a cell sheet stacking manipulation technology.,” Biomaterials. , 31, 7, 1646-1654, 2010.
[37] Sakaguchi K, Shimizu T, Horaguchi S, Sekine H, Yamato M, Umezu M, Okano T.,
“In vitro engineering of vascularized tissue surrogates.,” Sci Rep., 3, 1316, 2013.
[38] Nakamura M, Iwanaga S, Henmi C, Arai K, Nishiyama Y., “Biomatrices and biomaterials for future developments of bioprinting and biofabrication., ” Biofabrication., 2, 1, 2010.
[39] Lee JW, Choi YJ, Yong WJ, Pati F, Shim JH, Kang KS, Kang IH, Park J, Cho DW.,
“Development of a 3D cell printed construct considering angiogenesis for liver tissue engineering.,” Biofabrication., 8, 1, 2016.
[40] Lee H, Han W, Kim H, Ha DH, Jang J, Kim BS, Cho DW., “Development of Liver Decellularized Extracellular Matrix Bioink for Three-Dimensional Cell Printing-Based Liver Tissue Engineering.,” Biomacromolecules., 18, 4, 1229-1237, 2017.
[41] Zhang YS, Yue K, Aleman J, Moghaddam KM, Bakht SM, Yang J, Jia W, Dell'Erba V, Assawes P, Shin SR, Dokmeci MR, Oklu R, Khademhosseini A, “3D Bioprinting for Tissue and Organ Fabrication.,” Ann Biomed Eng. , 45, 1, 148-163, 2017.
[42] Crapo PM, Gilbert TW, Badylak SF., “An overview of tissue and whole organ decellularization processes.,” Biomaterials., 32, 12, 3233-3243, 2011.
[43] Badylak SF, Taylor D, Uygun K., “ Whole-organ tissue engineering:
decellularization and recellularization of three-dimensional matrix scaffolds.,”
Annu Rev Biomed Eng. , 13, 27-53, 2011.
[44] Crapo PM, Gilbert TW, Badylak SF., “An overview of tissue and whole organ decellularization processes.,” Biomaterials., 32, 12, 3233-3243, 2011.
101
[45] Gilbert TW, Freund JM, Badylak SF., “Quantification of DNA in biologic scaffold materials.,” J Surg Res. , 152, 1, 135-139, 2009.
[46] Cortiella J, Niles J, Cantu A, Brettler A, Pham A, Vargas G, Winston S, Wang J, Walls S, Nichols JE., “Influence of acellular natural lung matrix on murine embryonic stem cell differentiation and tissue formation.,” Tissue Eng Part A., 16, 8, 2562-2580, 2010.
[47] 今堀和友、山川民夫, 生化学辞典 第1版, 東京化学同人, 1984.
[48] Basak E Uygun, Alejandro Soto-Gutierrez, Hiroshi Yagi, Maria-Louisa Izamis, Maria A Guzzardi, Carley Shulman, Jack Milwid, Naoya Kobayashi, Arno Tilles, Francois Berthiaume, Martin Hertl, Yaakov Nahmias, Martin L Yarmush, and Korkut Uygun, “Organ reengineering through development of a transplantable recellularized liver graft using decellularized liver matrix,” Nat Med., 16, 7, 814-820, 2010.
[49] Soto-Gutierrez A, Zhang L, Medberry C, Fukumitsu K, Faulk D, Jiang H, Reing J, Gramignoli R, Komori J, Ross M, Nagaya M, Lagasse E, Stolz D, Strom SC, Fox IJ, Badylak SF., “ A whole-organ regenerative medicine approach for liver replacement.,” Tissue Eng Part C Methods, 17, 6, 677-686, 2011.
[50] Yagi H, Fukumitsu K, Fukuda K, Kitago M, Shinoda M, Obara H, Itano O, Kawachi S, Tanabe M, Coudriet GM, Piganelli JD, Gilbert TW, Soto-Gutierrez A, Kitagawa Y, “ Human-scale whole-organ bioengineering for liver transplantation: a regenerative medicine approach.,” Cell Transplant., 22, 2, 231-242, 2013.
[51] Park KM, Woo HM., “Porcine bioengineered scaffolds as new frontiers in regenerative medicine.,” Transplant Proc., 44, 4, 1146-1150, 2012.
[52] Park KM, Woo HM., “Systemic decellularization for multi-organ scaffolds in rats.,”
Transplant Proc, 44, 4, 1151-1154, 2012.
[53] Bao J, Shi Y, Sun H, Yin X, Yang R, Li L, Chen X, Bu H., “Construction of a portal implantable functional tissue-engineered liver using perfusion-decellularized matrix and hepatocytes in rats.,” Cell Transplant., 20, 5, 753-766, 2011.
102
[54] N. Shirakigawa, H. Ijima, T. Takei, “Decellularized liver as a practical scaffold with a vascular network template for liver tissue engineering,” J. Biosci. Bioeng., 114, 5, 546-551, 2012.
[55] Tunon MJ, Alvarez M, Culebras JM, Gonzalez-Gallego J., “ An overview of animal models for investigating the pathogenesis and therapeutic strategies in acute hepatic failure.,” World J Gastroentero. , 15, 25, 3086-3098, 2009.
[56] Bernal W, Hall C, Karvellas CJ, Auzinger G, Sizer E, Wendon J., “Arterial ammonia and clinical risk factors for encephalopathy and intracranial hypertension in acute liver failure.,” Hepatology. , 46, 6, 1844-1852, 2007.
[57] Éboli LP, Netto AA, Azevedo RA, Lanzoni VP, Paula TS, Goldenberg A, Gonzalez AM., “Evaluating the best time to intervene acute liver failure in rat models induced by d-galactosamine.,” Acta Cir Bras. , 31, 12, 783-792, 2016.
[58] S. PO., “Preparation of rat liver cells. I. Effect of Ca 2+ on enzymatic dispersion of isolated, perfused liver.,” Exp Cell Res., 74, 2, 450-454, 1972.
[59] 中村敏一, 初代培養肝細胞実験法, 学会出版センター, 1987.
[60] Murakami S, Ijima H, Ono T, Kawakami K., “Development of co-culture system of hepatocytes with bone marrow cells for expression and maintenance of hepatic functions.,” Int J Artif Organs, 27, 2, 118-126, 2004.
[61] Ijima H, Kawakami K., “Promotion of monolayer formation and high expression of ammonia metabolism of primary rat hepatocytes on arginine-glycine-aspartic acid-containing peptide-coated polystyrene dish.,” J Biosci Bioeng., 100, 1, 62-66, 2005.
[62] Takagi M, Kojima N, Yoshida T., “Analysis of the ammonia metabolism of rat primary hepatocytes and a human hepatocyte cell line Huh 7.,” Cytotechnology. , 32, 1, 9-15, 2000.
[63] 井嶋博之, “初代肝細胞の発泡体孔内三次元培養法を利用したハイブリッド型人工肝補
助システムの開発,” 九州大学大学院工学部機械工学科平成六年度博士論文, 1995.
103
[64] Yamashita Y, Shimada M, Tsujita E, Shirabe K, Ijima H, Nakazawa K, Sakiyama R, Fukuda J, Funatsu K, Sugimachi K., “Efficacy of a larger version of the hybrid artificial liver support system using a polyurethane foam/spheroid packed-bed module in a warm ischemic liver failure pig model for preclinical experiments.,”
Cell Transplant. , 12, 2, 101-107, 2003.
[65] H. B. Waynforth, P. A. Flecknell, Experimental and surgical technique in the rat second edition, Academic press.
[66] Guarino RD, Dike LE, Haq TA, Rowley JA, Pitner JB, Timmins MR., “Method for determining oxygen consumption rates of static cultures from microplate measurements of pericellular dissolved oxygen concentration.,” Biotechnol Bioeng. , 86, 7, 775-787, 2004.
[67] 牧野幹男, 桑島俊彦, 遠藤武, 宮内伊久子, “分光々度計による血液酸素飽和度測定
〔I〕等吸光点を含む二点測定法,” 臨床病理, 16, 6, 536-650, 1968.
[68] Serracino-Inglott F, Habib NA, Mathie RT., “Hepatic ischemia-reperfusion injury.,”
Am J Surg., 181, 2, 160-166, 2001.
[69] Fukuda K, Asoh S, Ishikawa M, Yamamoto Y, Ohsawa I, Ohta S., “Inhalation of hydrogen gas suppresses hepatic injury caused by ischemia/reperfusion through reducing oxidative stress.,”Biochem Biophys Res Commun., 361, 3, 670-674, 2007.
[70] Ohsawa I, Ishikawa M, Takahashi K, Watanabe M, Nishimaki K, Yamagata K, Katsura K, Katayama Y, Asoh S, Ohta S., “Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals.,” Nat Med. , 13, 6, 688-694, 2007.
[71] Hassanein W, Uluer MC, Langford J, Woodall JD, Cimeno A, Dhru U, Werdesheim A, Harrison J, Rivera-Pratt C, Klepfer S, Khalifeh A, Buckingham B, Brazio PS, Parsell D, Klassen C, Drachenberg C, Barth RN, LaMattina JC, “Recellularization via the bile duct supports functional allogenic and xenogenic cell growth on a decellularized rat liver scaffold.,” Organogenesis., 13, 1, 16-27, 2017.
104
[72] Bao J, Wu Q, Sun J, Zhou Y, Wang Y, Jiang X, Li L, Shi Y, Bu H,
“Hemocompatibility improvement of perfusion-decellularized clinical-scale liver scaffold through heparin immobilization.,” Sci Rep., p. doi: 10.1038/srep10756, 2015.
[73] Takahashi K, Yamanaka S., “Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors.,” Cell., 126, 4, 663-676, 2006.
[74] Takebe T, Sekine K, Enomura M, Koike H, Kimura M, Ogaeri T, Zhang RR, Ueno Y, Zheng YW, Koike N, Aoyama S, Adachi Y, Taniguchi H., “Vascularized and functional human liver from an iPSC-derived organ bud transplant.,” Nature., 499, 7459, 481-484, 2013.
105